Valute / ACRS
ACRS: Aclaris Therapeutics Inc
1.55
USD
0.06
(3.73%)
Il tasso di cambio ACRS ha avuto una variazione del -3.73% per oggi. Durante la giornata, lo strumento è stato scambiato ad un minimo di 1.50 e ad un massimo di 1.86.
Segui le dinamiche di Aclaris Therapeutics Inc. Le quotazioni in tempo reale aiutano a reagire velocemente alle variazioni di mercato. Scorrendo tra i diversi timeframe, è possibile monitorare le tendenze e le dinamiche dei tassi di cambio di minuti, ore, giorni, settimane e mesi. Utilizza queste informazioni per prevedere i cambiamenti del mercato e prendere decisioni di trading consapevoli.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
ACRS News
- Zacks Aclaris Therapeutics (ACRS) Expected to Beat Earnings Estimates: Should You Buy?
- Investing Aclaris Therapeutics stock soars after positive Phase 2a trial results
- Investing Aclaris reports positive results from ATI-2138 atopic dermatitis trial
- Investing Aclaris Therapeutics at HCW Conference: Strategic Moves and Future Plans
- Investing Aclaris Therapeutics joins Russell 3000 and Russell 2000 indexes
- Investing Aclaris Therapeutics to Participate in the H.C. Wainwright Inflammation & Immunology Virtual Conference
- Investing Aclaris Therapeutics initiates Phase 1 trial for ATI-052 antibody
- Investing Aclaris Therapeutics Initiates Phase 1a/1b Program for its Novel Bispecific Antibody ATI-052
- Investing InvestingPro’s Fair Value model captures 67% upside in Aclaris Therapeutics
- Investing H.C. Wainwright maintains Buy on Aclaris stock, $16 target
- Investing Aclaris Therapeutics at Jefferies Conference: Strategic Pipeline Advances
- Investing Aclaris begins phase 2 trial for atopic dermatitis drug
- Investing Aclaris Therapeutics to Participate in Two June Healthcare Conferences
- Investing Wedbush sets Aclaris stock Outperform with $8 target
- Benzinga This Arista Networks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Aclaris Therapeutics (NASDAQ:ACRS), Alkermes (NASDAQ:ALKS)
- Investing Insurance broker Acrisure valued at $32 billion in funding round led by Bain Capital
- Investing H.C. Wainwright cuts Aclaris stock price target to $16
- Seeking Alpha Aclaris: History Of Failures, And Recent Acquisition Of A 'Blockbuster Potential' Molecule
Intervallo Giornaliero
1.50
1.86
Intervallo Annuale
1.05
5.17
- Chiusura Precedente
- 1.55
- Apertura
- 1.61
- Bid
- 1.55
- Ask
- 1.85
- Minimo
- 1.50
- Massimo
- 1.86
- Volume
- 4.911 K
- Variazione giornaliera
- -3.73%
- Variazione Mensile
- 7.64%
- Variazione Semestrale
- -35.95%
- Variazione Annuale
- 12.32%
30 luglio, mercoledì
12:15
USD
- Agire
- 104 K
- Fcst
- 57 K
- Prev
- -33 K
12:30
USD
- Agire
- 3.0%
- Fcst
- 0.4%
- Prev
- -0.5%
12:30
USD
- Agire
- 2.0%
- Fcst
- 3.6%
- Prev
- 3.8%
12:30
USD
- Agire
- 2.5%
- Fcst
- 3.3%
- Prev
- 3.5%
12:30
USD
- Agire
- 2.1%
- Fcst
- 3.1%
- Prev
- 3.7%
12:30
USD
- Agire
- 1.4%
- Fcst
- 0.8%
- Prev
- 0.5%
12:30
USD
- Agire
- 6.3%
- Fcst
- -1.5%
- Prev
- -3.1%
14:00
USD
- Agire
- -0.8%
- Fcst
- 1.6%
- Prev
- 1.8%
14:00
USD
- Agire
- -2.8%
- Fcst
- 9.6%
- Prev
- 1.1%
14:00
USD
- Agire
- 72.0
- Fcst
- Prev
- 72.6
14:30
USD
- Agire
- 7.698 M
- Fcst
- 0.914 M
- Prev
- -3.169 M
14:30
USD
- Agire
- 0.690 M
- Fcst
- 0.114 M
- Prev
- 0.455 M
14:30
USD
- Agire
- 1.317 M
- Fcst
- 0.738 M
- Prev
- -0.740 M
14:30
USD
- Agire
- 0.130 M
- Fcst
- -0.004 M
- Prev
- 0.095 M
14:30
USD
- Agire
- 3.635 M
- Fcst
- -0.111 M
- Prev
- 2.931 M
14:30
USD
- Agire
- 0.676 M
- Fcst
- 0.915 M
- Prev
- 0.282 M
14:30
USD
- Agire
- 0.739 M
- Fcst
- 0.608 M
- Prev
- 0.003 M
14:30
USD
- Agire
- -2.724 M
- Fcst
- 0.879 M
- Prev
- -1.738 M
14:30
USD
- Agire
- -0.025 M
- Fcst
- Prev
- 0.087 M
14:30
USD
- Agire
- -0.1%
- Fcst
- Prev
- 1.6%
18:00
USD
- Agire
- Fcst
- Prev
18:00
USD
- Agire
- 4.50%
- Fcst
- Prev
- 4.50%
18:30
USD
- Agire
- Fcst
- Prev